Long-term outcome of complete cytogenetic responders after imatinib 400 mg in late chronic phase, philadelphia-positive chronic myeloid leukemia: the GIMEMA Working Party on CML.

Francesca Palandri; Ilaria Iacobucci; Giovanni Martinelli; Marilina Amabile; Angela Poerio; Nicoletta Testoni; Simona Soverini; Fausto Castagnetti; Antonio De Vivo; Massimo Breccia

doi:10.1200/JCO.2007.13.2373

Long-term outcome of complete cytogenetic responders after imatinib 400 mg in late chronic phase, philadelphia-positive chronic myeloid leukemia: the GIMEMA Working Party on CML.

NobleID: NI7P19W58R26S77
Persistent link: https://nobleid.org/ark:/48914/w1/20260515/FA2FEAAD

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/FA2FEAAD.svg?ark=w1%2F20260515%2FFA2FEAAD&value=id)](https://nobleid.org/work/w1/20260515/FA2FEAAD)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Long-term outcome of complete cytogenetic responders after imatinib 400 mg in late chronic phase, philadelphia-positive chronic myeloid leukemia: the GIMEMA Working Party on CML.

NobleID: NI7P19W58R26S77
Persistent link: https://nobleid.org/ark:/48914/w1/20260515/FA2FEAAD

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/FA2FEAAD.svg?ark=w1%2F20260515%2FFA2FEAAD&value=id)](https://nobleid.org/work/w1/20260515/FA2FEAAD)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work